Archived — Government of Canada Investing in Innovation

Archived information

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.

For immediate release
May 11, 2012

Richmond Hill, Ontario — Costas Menegakis, Member of Parliament for Richmond Hill, announced a federal investment of up to $539,000 today. This investment will allow Qvella Corporation to develop and bring to market an innovative bacteria identification system.

"Our government is committed to investing in businesses to create jobs, growth and long-term prosperity in southern Ontario," said MP Menegakis. "Through the Investing in Business Innovation Initiative, we are helping Qvella Corporation develop faster techniques for diagnosing bacterial infections, leading to faster treatments." 

The investment is being provided through the Federal Economic Development Agency for Southern Ontario's Investing in Business Innovation (IBI) initiative. The investment of up to $539,000 in Qvella Corporation will help the company complete the development of its bacteria identification system and accelerate the commercialization of the company's sample preparation and bacteria testing platform. This will result in better patient care, reduced healthcare costs and the creation of twenty high-quality jobs in the sciences sector in southern Ontario. Private sector funding is also being leveraged at a ratio of two to one on the IBI investment from the Health Technology Exchange and the Inception Angel Group.

Qvella Corporation is a molecular diagnostics company focused on bringing new sample preparation and detection technologies to clinical microbiology. There are compelling clinical needs for microbiology to be better, faster and cheaper. This IBI investment will facilitate the development of faster and less expensive technologies to meet these needs. For example, the new technology will reduce the diagnosis time from one-to-three days to a mere half-hour. Faster results will allow doctors to prescribe the right antibiotics at the point of diagnosis, thereby improving patient outcome, reducing treatment cost and decreasing antibiotic resistance.

"FedDev is providing crucial injections of capital for technology start-ups by partnering with angel groups. This accelerates the development of products, companies, and indeed, industrial sectors, said Qvella's President, Dr. Tino Alavie. "Qvella is grateful to have the support of FedDev at such a critical juncture in our development and hope to be able to build a company that grows and fulfills the promise of job creation and technology prowess in Southern Ontario."

The objective of IBI is to boost private sector investment in start-up businesses to accelerate the development of new products, processes and practices. Under IBI, private sector investors must invest two dollars for every dollar invested by the Initiative.

FedDev Ontario was created as part of Canada's Economic Action Plan to support businesses and communities in southern Ontario. Now in its second year of operation, the Agency has launched a number of initiatives to create a Southern Ontario Advantage and place the region in a strong position to compete in the global economy. These initiatives are designed to support businesses and other organizations through partnerships and investments in skills and training; innovation; research and development; and increased productivity. To learn more, please visit www.feddevontario.gc.ca or call 1-866-593-5505.

Follow us on Twitter @FedDevOntario

– 30 –

For more information, contact:

Stephanie Thomas
Press Secretary
Office of the Honourable Gary Goodyear
613-960-7728

Media Relations
FedDev Ontario
519-585-2917

Date modified: